Efficacy and Safety of MA and MAL on reducing body weight and body fat

Not Applicable

Active, not recruiting

• Conditions: Not Applicable

• Registration Number: KCT0004012
• Lead Sponsor: MSC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 June 2019

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1) Adults 20 years of age or older and 65 years of age or younger
2) Body mass index (BMI) is greater than 25, less than 32
3) The person who agrees to participate in this study and wrote the written informed consent

Exclusion Criteria

1) Those with severe cerebrovascular disease, heart disease (angina pectoris, myocardial infarction, heart failure, or arrhythmia requiring treatment) within the past 6 months.
2) Those taking drugs affecting body weight within the past month (absorption inhibitors and appetite suppressants, health functional foods / supplements related to obesity improvement, psychiatric drugs such as depression, beta-blockers, diuretics, oral contraceptive pills, steroids and female hormones)
3) Unadjusted hypertension patients (blood pressure of 160/100 mmHg or higher)
4) Diabetic patients with fasting blood glucose levels greater than 126 mg / dl or with oral hypoglycemic agents or insulin
5) Thyroid stimulating hormone (TSH) less than 0.1 µU / ml or more than 10 µU / ml or currently taking thyroid hormone
6) Creatinine is at least twice the normal upper limit of the test facility
7) Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) is more than three times the normal upper limit.
8) Persons with severe gastrointestinal disturbances who are suffering from ingestion of test food
9) Those who were admitted to the hospital, or have received medication or rehabilitation due to alcohol use
10) Those who cannot exercise because of musculoskeletal disorders
11) Those who participated in the commercial obesity program within the last 3 months
12) Those who participated or planned to participate in other clinical trials within the past one month

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body fat percentage and fat mass through Dual-energy X-ray absorptiometry (DEXA)

Secondary Outcome Measures

Name	Time	Method
Body weight;Waist circumference;Hip circumference;Body mass index;Blood lipid;C-Reactive Protein (CRP)